Header image

Molecular neuro-oncology - from basic research to clinical applications (Neuro-Oncology Parallel Session)

Tracks
Hall 6
Monday, October 14, 2024
8:00 AM - 9:30 AM
Hall 06

Details

Oral Presentations duration (each): 7 minutes + 1 minute Q&A


Speakers & Chairs

Dr Franz Ricklefs
Attending, Principal Investigator
University Medical Center Hamburg-eppendorf

Chair

Prof Martin Van Den Bent
Head of the Neuro-Oncology
Erasmus Medical Center

Chair

Dr Franz Ricklefs
Attending, Principal Investigator
University Medical Center Hamburg-eppendorf

Methylation based subclassification of glioblastoma - clinical utility

8:00 AM - 8:10 AM
Agenda Item Image
Dr Giuseppe Maria Della Pepa
Consultant
Fondazione Policlincio Gemelli Irccs

Dissecting the microenvironment of malignant gliomas: translational approaches and prognostic implications

8:10 AM - 8:20 AM
Prof Martin Van Den Bent
Head of the Neuro-Oncology
Erasmus Medical Center

INDIGO: A global, randomized, double-blinded, phase 3 study of vorasidenib versus placebo in patients with residual or recurrent grade 2 glioma with an IDH1/2 mutation

8:20 AM - 8:30 AM
Dr Harald Krenzlin
Attending
University Hospital Mainz

The role of surgery in IDH wildtype diffuse astrocytomas

8:30 AM - 8:37 AM
Dr Giuseppe Maimone
Doctor
AUSL della Romagna

Advances in postoperative adjuvant therapy for primary Glioblastoma. First results in an Autologous Dendritic Cells Vaccine phase II study.

8:37 AM - 8:44 AM
Dr Tobias Mederer
Resident
University Hospital Regensburg

Liquid biopsies in meningioma - plasma cell-free DNA as a potential biomarker for meningioma tumor burden

8:44 AM - 8:51 AM
Agenda Item Image
Dr Eric Freund
Resident
Medical University of Vienna

PSGL-1 and other markers of tumor-associated macrophages and microglial cells exhibit high intratumoral heterogeneity in human glioblastoma tissue

8:58 AM - 9:05 AM
Agenda Item Image
Dr Manina Etter
Resident
Department of Neurosurgery Universitätsspital Basel

Identification of plasma-derived diagnostic and predictive biomarkers for gliomas

9:05 AM - 9:12 AM
Agenda Item Image
Dr Tong Meng
Associate Chief Surgeon
Shanghai General Hospital

Clinical-proteomic classification and precision treatment strategy of chordoma

9:12 AM - 9:19 AM
Discussion

Discussion

9:19 AM - 9:30 AM
loading